Magharbil Enas, Al-Qahtani Faisal, Al-Enazi Maram, Badawi Abdulrahman H, Alyousif Nora, Magliyah Moustafa S, Al-Dhibi Hassan
Vitreoretinal and Uveitis Division, King Khaled Eye Specialist Hospital, PO Box 7141, Riyadh, 11462, Saudi Arabia.
Uveitis department, Jeddah Eye Hospital, Jeddah, Saudi Arabia.
J Ophthalmic Inflamm Infect. 2025 Jul 1;15(1):51. doi: 10.1186/s12348-025-00511-8.
To study the clinical picture, outcomes and the complications of acute retinal necrosis (ARN) in a tertiary eye hospital.
This is retrospective chart review of all patients who were diagnosed with ARN and were treated and followed up at King Khaled Eye Specialist Hospital (KKESH). Details of clinical examinations, Polymerase Chain Reaction (PCR) results, systemic and topical treatments, complications and managements of complications were obtained.
Twenty eight eyes of 26 patients were included. The results of PCR were positive in 22 eyes. Systemic antiviral therapy with intravenous Acyclovir 10 mg/Kg three times daily was given to all cases. Eight patients were treated with intravitreal ganciclovir injections. Fifteen eyes (56.3%) had rhegmatogenous retinal detachment (RRD) and 11 of them had surgical interventions. The risk of developing RRD was significantly high in severe vitritis (P = 0.007, OR = 3.825), diffuse or multifocal retinitis (P = 0.010, OR = 1.04) and the larger extent of retinitis (P = 0.016). The final visual outcome was worse among eyes which developed RRD (LogMAR 1.6 ± 0.94, Snellen = 20/800) than eyes which did not develop RRD (LogMAR 0.81 ± 0.84, Snellen = 20/125) and the difference was statistically significant (P = 0.031).
The visual outcomes of ARN are significantly worse in eyes which develop RRD. More severe and larger extent of posterior segment involvement confer higher risks of RRD development in ARN.
在一家三级眼科医院研究急性视网膜坏死(ARN)的临床表现、治疗结果及并发症。
这是一项对所有在沙特国王哈立德眼科专科医院(KKESH)被诊断为ARN并接受治疗及随访的患者的回顾性病历分析。获取了临床检查细节、聚合酶链反应(PCR)结果、全身及局部治疗情况、并发症及并发症处理措施。
纳入26例患者的28只眼。22只眼PCR结果呈阳性。所有病例均接受静脉注射阿昔洛韦10mg/kg、每日3次的全身抗病毒治疗。8例患者接受了玻璃体内注射更昔洛韦治疗。15只眼(56.3%)发生了孔源性视网膜脱离(RRD),其中11只眼接受了手术干预。在严重葡萄膜炎(P = 0.007,OR = 3.825)、弥漫性或多灶性视网膜炎(P = 0.010,OR = 1.04)以及视网膜炎范围较大(P = 0.016)的情况下,发生RRD的风险显著升高。发生RRD的眼最终视力结果(LogMAR 1.6±0.94,Snellen = 20/800)比未发生RRD的眼(LogMAR 0.81±0.84,Snellen = 20/125)更差,差异具有统计学意义(P = 0.031)。
发生RRD的ARN患者视力结果明显更差。ARN患者后段受累更严重、范围更大时,发生RRD的风险更高。